Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Meridian Bioscience
(NQ:
VIVO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Meridian Bioscience
< Previous
1
2
3
4
Next >
DoubleVerify To Join S&P SmallCap 600 On January 31
January 26, 2023
Via
Benzinga
Meridian Bioscience's Return On Capital Employed Overview
December 29, 2022
Via
Benzinga
Cannabis Stock Gainers And Losers From December 12, 2022
December 12, 2022
Via
Benzinga
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
October 07, 2022
This quartet of stocks has plenty of growth ahead and is already profitable.
Via
The Motley Fool
Silk Road Medical Stock Scores Relative Strength Rating Upgrade
September 28, 2022
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level.
Via
Investor's Business Daily
Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark
September 26, 2022
Penumbra stock cleared a key 80-plus relative strength benchmark Monday, with a jump to 87 from 79 on Friday.
Via
Investor's Business Daily
Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners - Read For How Much
July 07, 2022
Via
Benzinga
Looking Into Meridian Bioscience's Return On Capital Employed
August 26, 2022
Meridian Bioscience (NASDAQ:VIVO) brought in sales totaling $67.77 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 125.52%, resulting in a loss of $7.34...
Via
Benzinga
Meridian Bioscience: Q3 Earnings Insights
August 05, 2022
Meridian Bioscience (NASDAQ:VIVO) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 5, 2022
August 05, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Via
Benzinga
Preview: Meridian Bioscience's Earnings
August 04, 2022
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Meridian...
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
July 29, 2022
Via
Benzinga
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
July 22, 2022
Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022
July 08, 2022
Via
Benzinga
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4
July 07, 2022
AMC Entertainment (AMC) stock is in the news today as investors in the theater company prepare for a potential catalyst coming next month!
Via
InvestorPlace
Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement
July 07, 2022
VIVO stock is a hot topic on Wall Street today, not just because Meridian Biosciences released a fiscal update, but also due to takeover news.
Via
InvestorPlace
Cannabis Stock Gainers And Losers From July 6, 2022
July 06, 2022
GAINERS: Tilray Brands (NASDAQ:TLRY) shares closed up 8.02% at $3.50
Via
Benzinga
Marijuana Stock Movers For June 30, 2022
June 30, 2022
GAINERS: Marrone Bio Innovations (NASDAQ:MBII) shares closed up 6.42% at $1.16
Via
Benzinga
EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform
June 30, 2022
Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors.
Via
Benzinga
Cannabis Stock Movers For June 29, 2022
June 29, 2022
GAINERS: Cansortium (OTC:CNTMF) shares closed up 4.07% at $0.17
Via
Benzinga
Cannabis Stock Movers For June 28, 2022
June 28, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 16.35% at $0.79
Via
Benzinga
Cannabis Stock Gainers And Losers From June 27, 2022
June 27, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 46.08% at $0.02
Via
Benzinga
Cannabis Stock Gainers And Losers From June 17, 2022
June 17, 2022
GAINERS: Origin Agritech (NASDAQ:SEED) shares closed up 10.10% at $7.63
Via
Benzinga
Cannabis Stock Movers For June 9, 2022
June 09, 2022
GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 35.09% at $1.29 LOSERS:
Via
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 8, 2022
June 08, 2022
GAINERS: Cansortium (OTC:CNTMF) shares closed up 12.00% at $0.22
Via
Benzinga
Cannabis Stock Movers For June 6, 2022
June 06, 2022
GAINERS: Leviathan Natural Prods (OTC:LVCNF) shares closed up 17.12% at $0.87
Via
Benzinga
Looking Into Meridian Bioscience's Return On Capital Employed
June 01, 2022
According to Benzinga Pro, during Q2, Meridian Bioscience (NASDAQ:VIVO) earned $28.75 million, a 87.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $111.23 million...
Via
Benzinga
This Company Looks To Make Its Value-Added Technologies Benefit Smartphone Consumers In China — Then The World?
May 20, 2022
Photo by Deep Advani on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Cannabis Stock Gainers And Losers From May 19, 2022
May 19, 2022
GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 7.42% at $0.99
Via
Benzinga
Marijuana Stock Movers For May 9, 2022
May 09, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 9.00% at $1.09
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.